Page last updated: 2024-11-02

o-phthalaldehyde and Chronic Disease

o-phthalaldehyde has been researched along with Chronic Disease in 1 studies

o-Phthalaldehyde: A reagent that forms fluorescent conjugation products with primary amines. It is used for the detection of many biogenic amines, peptides, and proteins in nanogram quantities in body fluids.
phthalaldehyde : A dialdehyde in which two formyl groups are attached to adjacent carbon centres on a benzene ring.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Use of the beryllium LPT (BeLPT) in medical surveillance identifies beryllium sensitization at low exposure with chronic beryllium disease (CBD) that leads to physiologic impairment and need for immunosuppressive medications."4.88The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. ( Hines, SE; Maier, LA; Pacheco, K, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hines, SE1
Pacheco, K1
Maier, LA1

Reviews

1 review available for o-phthalaldehyde and Chronic Disease

ArticleYear
The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.
    Current opinion in allergy and clinical immunology, 2012, Volume: 12, Issue:2

    Topics: Allergens; Animals; Berylliosis; Beryllium; Chronic Disease; Female; Humans; Hypersensitivity; Lymph

2012